Kim Golodetz | Investor Relations |
Corinne Le Goff | President and Chief Executive Officer |
Jeffrey Church | Chief Financial Officer |
Khursheed Anwer | Chief Science Officer |
Nicholas Borys | Chief Medical Officer |
Emily Bodnar | H.C. Wainwright & Co, LLC |
James Molloy | Alliance Global Partners |
David Bautz | Zacks Small-Cap Research |
Good morning. My name is Marliese, and I will be your operator today. At this time, I would like to welcome you to Imunon's Third Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise.
Following the speakers' prepared remarks, there will be a question-and-answer session.